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Summary:
Thiazide diuretics are widely used to treat hypertension, 
but their use Is associated with impaired glucose toler­
ance. We propose that the diabetogenic action of thia­
zides may be due to their ability to open calcium-activ 
ated potassium (KCn) channels in pancreatic /i-cells.
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Thiazide diuretics are a widely used therapy for 
hypertension. However, glucose intolerance de­
velops in about 3% of hypertensive patients treated 
with thiazides.1*” The mechanism of this adverse 
effect is poorly understood. Glucose intolerance 
caused by thiazide diuretics is dose-dependent and 
usually reversible after discontinuation of treat­
ment.1,2 It is functionally correlated with hypokal- 
aemia and has been proposed to be secondary to it, 
In some studies prevention of the decline in serum 
potassium prevents hyperglycaemia- and hypokal- 
aemia is associated with a reduced pancreatic /i-cell 
response to glucose. However, it has also been sug­
gested that hypokalaemia may be an aggravating 
factor rather than a primary stimulus.J Besides the 
effect of thiazides on pancreatic cells, extra-pan­
creatic; mechanisms have also been proposed to 
explain the diabetogenic action of the thiazide 
diuretics;1,5 We wish to propose a novel hypothesis 
regarding the diabetogenic effects of thiazides based 
on their action on a class of potassium (K) channels, 
which in turn may be related to their effects on 
intracellular pH (pHj) through inhibition of car­
bonic anhydrase.
In the pancreas, depolarisation of the plasma 
membrane by closure of K channels and opening of 
cation and chloride channels leads to opening of 
voltage-dependent calcium channels and influx of 
calcium,r,"a The resultant increase of intracellular 
calcium ([Ca2+]|) is crucial to the process of insulin 
release; drugs which interfere with these mechan­
isms inhibit insulin release. It is known that diazox­
ide, a drug structurally related to the thiazides, 
hvperpolarises pancreatic /f-cells by opening a spe-
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cific class of ATP-dopendent potassium channels 
(KATP channels) and that the consequent hyper­
polarisation impairs insulin release,*1”11 and prob­
ably accounts for the diabetogenic effect of this 
drug. This effect of diazoxide can be inhibited by 
agents such as glibenclamide which block KATP 
channels and are used clinically as hypoglycaemic 
agents. It has also been proposed that diazoxide 
exerts direct vasodilator activity by activating the 
same, or a similar, KATI> channel in vascular smooth 
muscle cells.12
Recently it has been found that hydrochlorothia­
zide also reduces insulin release. This action of 
hydrochlorothiazide was associated with a fall in 
glucose-stimulated **r,Ca“+ uptake in /J-cells.^ As 
discussed above, influx of calcium is one of the 
most distal steps in stinnilus-secretion coupling in 
pancreatic /i-cells and is crucial to insulin release.7 
We propose that the action of hydrochlorothiazide 
on calcium influx into the pancreatic /i-cell may be 
by the same mechanism by which the drug inhibits 
calcium entry into vascular smooth muscle cells. 
Our group has previously shown that hydrochloro­
thiazide relaxes vascular smooth muscle cells 
through an inhibition of calcium influx.H This ef­
fect of hydrochlorothiazide is associated with an 
increase in *mRb efflux, a marker of K* efflux,15 
indicating that hydrochlorothiazide increases m em ­
brane permeability to K f ions, probably by opening 
K channels. The effects of hydrochlorothizide on 
vascular tone, [Ca2+li and miRb efflux wore inhibited 
by charybdotoxin, a blocker of calcium-activated 
potassium (KCJ  channels,UATl In contrast, the KAn> 
channel blocker glibenclamide did not affect hydro­
chlorothiazide-induced vasorelaxation or m’Rb ef­
flux.tn This is consistent with a previous report
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692 showing that hydrochlorothiazide does not affect 
the opening of single KATP channels in the ß-cell 
plasma membrane.16 These data suggest that the 
opening of calcium activated K channels (KCû) 
rather than KATP channels mediates the vasodilator 
effect of thiazides. Interestingly, electrophysiolo- 
gical studies have shown that cicletanine, a thia­
zide-like drug containing a furopyridine group, 
causes membrane hyperpolarisation in isolated 
canine femoral arteries17 probably by an action on 
KCa channels. KCa channels are present in pancreatic 
ß-cells5 and by analogy with the potassium channel 
opening properties of diazoxide it is very likely that 
the effect of hydrochlorothiazide on KC(l channels 
hyperpolarises the /3-cell membrane, leading to a 
reduced insulin release. This effect could explain 
the inhibitory action of hydrochlorothiazide on
insulin production.
On-going studies in our department suggest that 
the K channel opening properties of hydrochloro­
thiazide may depend on changes in intracellular pH 
(pHJ. Effects of hydrochlorothiazide on pH{ appear 
to be associated with the ability of the drug to 
inhibit carbonic anhydrase activity.18 Interestingly 
others have shown that pre-treatment with acetazo- 
lamide, an inhibitor of carbonic anhydrase, caused 
decreased glucose tolerance in mice and decreased 
secretion of insulin by isolated pancreatic islets.lH 
These findings support the idea that inhibition of 
carbonic anhydrase activity may modulate pan­
creatic ß-cell funçtion and glucose tolerance, In 
addition, there are data indicating that bendro- 
flumethiazide, which unlike other thiazide diuret­
ics has minimal inhibitory effects on carbonic anhy­
drase at therapeutic levels, does not impair glucose 
tolerance in hypertensive patients20,21 and even im­
proves glucose tolerance in the long term,22
As a result of our studies we postulate that thia­
zide-induced hyperglucaemia is, at least in part, 
due to hyperpolarisation of the /3-cell via an action 
on KCa channels. This effect may be caused by 
inhibition of carbonic anhydrase by hydrochloro­
thiazide resulting in an increase in pHi( Opening of
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Figure 1  Diagrammatic scheme illustrating the proposed 
mechanism of inhibition of insulin release by thiazides. KCil- 
calcium-activated K channel, KATP-ATP-dependent K channel. 
VOC: voltage-operated calcium channel
KCa channels leads to hyperpolarisation of the cell 
membrane and closure of voltage-operated calcium  
channels, hence [Ca“*], decreases (Figure 1). In vas­
cular smooth muscle this leads to vasodilation, 
whereas in pancreatic ß-cells this leads to reduced 
insulin release and impaired glucose tolerance.
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